129 related articles for article (PubMed ID: 30955859)
1. p53 suppression is essential for oncogenic SPAG5 upregulation in lung adenocarcinoma.
Wang T; Li K; Song H; Xu D; Liao Y; Jing B; Guo W; Hu M; Kuang Y; Sun B; Ling J; Zhang T; Xu J; Yao F; Deng J
Biochem Biophys Res Commun; 2019 May; 513(2):319-325. PubMed ID: 30955859
[TBL] [Abstract][Full Text] [Related]
2. SPAG5 contributes to the progression of gastric cancer by upregulation of Survivin depend on activating the wnt/β-catenin pathway.
Liu G; Liu S; Cao G; Luo W; Li P; Wang S; Chen Y
Exp Cell Res; 2019 Jun; 379(1):83-91. PubMed ID: 30904482
[TBL] [Abstract][Full Text] [Related]
3. SPAG5 upregulation contributes to enhanced c-MYC transcriptional activity via interaction with c-MYC binding protein in triple-negative breast cancer.
Li M; Li A; Zhou S; Lv H; Yang W
J Hematol Oncol; 2019 Feb; 12(1):14. PubMed ID: 30736840
[TBL] [Abstract][Full Text] [Related]
4. SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinoma.
Yang YF; Zhang MF; Tian QH; Fu J; Yang X; Zhang CZ; Yang H
Mol Cancer; 2018 Aug; 17(1):117. PubMed ID: 30089483
[TBL] [Abstract][Full Text] [Related]
5. SPAG5 is associated with unfavorable prognosis in patients with lung adenocarcinoma and promotes proliferation, motility and autophagy in A549 cells.
Huang R; Li A
Exp Ther Med; 2020 Nov; 20(5):77. PubMed ID: 32968434
[TBL] [Abstract][Full Text] [Related]
6. Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction.
Fortunato O; Boeri M; Moro M; Verri C; Mensah M; Conte D; Caleca L; Roz L; Pastorino U; Sozzi G
Cell Death Dis; 2014 Dec; 5(12):e1564. PubMed ID: 25501825
[TBL] [Abstract][Full Text] [Related]
7. GMDS knockdown impairs cell proliferation and survival in human lung adenocarcinoma.
Wei X; Zhang K; Qin H; Zhu J; Qin Q; Yu Y; Wang H
BMC Cancer; 2018 May; 18(1):600. PubMed ID: 29843634
[TBL] [Abstract][Full Text] [Related]
8. miR-539 inhibits prostate cancer progression by directly targeting SPAG5.
Zhang H; Li S; Yang X; Qiao B; Zhang Z; Xu Y
J Exp Clin Cancer Res; 2016 Apr; 35():60. PubMed ID: 27037000
[TBL] [Abstract][Full Text] [Related]
9. Deregulated lncRNA expression profile in the mouse lung adenocarcinomas with KRAS-G12D mutation and P53 knockout.
Zhang M; Jiang N; Cui R; Du S; Ou H; Chen T; Ge R; Ma D; Zhang J
J Cell Mol Med; 2019 Oct; 23(10):6978-6988. PubMed ID: 31410985
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of MAGEA2 has a prognostic significance and is a potential therapeutic target for patients with lung cancer.
Ujiie H; Kato T; Lee D; Hu HP; Fujino K; Kaji M; Kaga K; Matsui Y; Yasufuku K
Int J Oncol; 2017 Jun; 50(6):2154-2170. PubMed ID: 28498455
[TBL] [Abstract][Full Text] [Related]
11. High expression of SPAG5 sustains the malignant growth and invasion of breast cancer cells through the activation of Wnt/β-catenin signalling.
Jiang J; Wang J; He X; Ma W; Sun L; Zhou Q; Li M; Yu S
Clin Exp Pharmacol Physiol; 2019 Jun; 46(6):597-606. PubMed ID: 30854682
[TBL] [Abstract][Full Text] [Related]
12. Induction of p21(Waf1/Cip1) by garcinol via downregulation of p38-MAPK signaling in p53-independent H1299 lung cancer.
Yu SY; Liao CH; Chien MH; Tsai TY; Lin JK; Weng MS
J Agric Food Chem; 2014 Mar; 62(9):2085-95. PubMed ID: 24533688
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of Merm1/Wbscr22 attenuates sensitivity of H460 non-small cell lung cancer cells to SN-38 and 5-FU without alteration to p53 expression levels.
Yan D; Zheng X; Tu L; Jia J; Li Q; Cheng L; Wang X
Mol Med Rep; 2015 Jan; 11(1):295-302. PubMed ID: 25352209
[TBL] [Abstract][Full Text] [Related]
14. SPAG5 promotes proliferation and suppresses apoptosis in bladder urothelial carcinoma by upregulating Wnt3 via activating the AKT/mTOR pathway and predicts poorer survival.
Liu JY; Zeng QH; Cao PG; Xie D; Yang F; He LY; Dai YB; Li JJ; Liu XM; Zeng HL; Fan XJ; Liu L; Zhu YX; Gong L; Cheng Y; Zhou JD; Hu J; Bo H; Xu ZZ; Cao K
Oncogene; 2018 Jul; 37(29):3937-3952. PubMed ID: 29662193
[TBL] [Abstract][Full Text] [Related]
15. SOX6 suppresses the development of lung adenocarcinoma by regulating expression of p53, p21
Lv L; Zhou M; Zhang J; Liu F; Qi L; Zhang S; Bi Y; Yu Y
FEBS Open Bio; 2020 Jan; 10(1):135-146. PubMed ID: 31729835
[TBL] [Abstract][Full Text] [Related]
16. Effect of exogenous p51a gene on the growth and chemo sensitivity of human lung adenocarcinoma cell lines.
Shen Q; Wang H; Zhang L
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S383-S388. PubMed ID: 30095026
[TBL] [Abstract][Full Text] [Related]
17. An anthraquinone derivative from Luffa acutangula induces apoptosis in human lung cancer cell line NCI-H460 through p53-dependent pathway.
Vanajothi R; Srinivasan P
J Recept Signal Transduct Res; 2016; 36(3):292-302. PubMed ID: 26585176
[TBL] [Abstract][Full Text] [Related]
18. [Research on expression and control of p16 and p21 by wild-type p53 gene in two lung adenocarcinoma cell lines].
Jin Y; Yan CH; Wu Y; Liu Y; Zhang GY; Li P; Fu SB
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Oct; 20(5):409-12. PubMed ID: 14556194
[TBL] [Abstract][Full Text] [Related]
19. HDAC2 overexpression confers oncogenic potential to human lung cancer cells by deregulating expression of apoptosis and cell cycle proteins.
Jung KH; Noh JH; Kim JK; Eun JW; Bae HJ; Xie HJ; Chang YG; Kim MG; Park H; Lee JY; Nam SW
J Cell Biochem; 2012 Jun; 113(6):2167-77. PubMed ID: 22492270
[TBL] [Abstract][Full Text] [Related]
20. VEGFR3 inhibition chemosensitizes lung adenocarcinoma A549 cells in the tumor-associated macrophage microenvironment through upregulation of p53 and PTEN.
Li Y; Weng Y; Zhong L; Chong H; Chen S; Sun Y; Li W; Shi Q
Oncol Rep; 2017 Nov; 38(5):2761-2773. PubMed ID: 29048623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
